Ertapenem Injection Market Professional Survey Report 2019

Ertapenem Injection Market

Ertapenem injection is used to treat certain serious infections, including pneumonia and urinary tract, skin, diabetic foot, gynecological, pelvic, and abdominal (stomach area) infections, that are caused by bacteria. It is also used for the prevention of infections following colorectal surgery. Ertapenem is in a class of medications called carbapenem antibiotics.The global Ertapenem Injection market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019–2025.

This report focuses on Ertapenem Injection volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ertapenem Injection market size by analyzing historical data and future prospect.

Report Sample includes:

- Table of Contents

- List of Tables & Figures

- Charts

- Research Methodology

Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-ertapenem-injection-2019-884

Regionally, this report categorizes the production, apparent consumption, export and import of Ertapenem Injection in North America, Europe, China, Japan, Southeast Asia and India.

For each manufacturer covered, this report analyzes their Ertapenem Injection manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:

Merck
Endo
Aurobindo Pharma
ACS Dobfar

Segment by Regions

North America
Europe
China
Japan
Southeast Asia
India

Segment by Type

INVANZ
Generic Version

Segment by Application

Adult
Pediatric

Get the Complete Report & TOC at https://www.24marketreports.com/life-sciences/global-ertapenem-injection-2019-884

CONTACT US:

276 5th Avenue, New York , NY 10001,United States

International: (+1) 646 781 7170

Email: [email protected]